Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis.

Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis.
复制标题

豆甾醇通过激活结肠炎中的丁酸-PPARγ 轴来恢复 Treg/Th17 细胞的平衡

DOI:
10.3389/fimmu.2021.741934
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Liu F
Liu F
中科院分区:
医学2区
文献类型:
--
作者:
Wen S;He L;Zhong Z;Zhao R;Weng S;Mi H;Liu F

文献摘要

相似文献

炎症性肠病(IBD)是一种以肠道微生物区系失衡和调节性T(Treg)/T辅助T细胞(Th17)免疫失衡为特征的慢性炎症性疾病。豆甾醇,一种从植物中提取的甾醇,已经显示出抗炎作用。本研究旨在探讨豆甾醇对实验性结肠炎的治疗作用及其相关机制。在葡聚糖硫酸钠(DSS)诱导的结肠炎模型中,豆甾醇治疗恢复了Treg/Th17平衡,并改变了肠道微生物区系。移植接受豆甾醇治疗的小鼠的粪便微生物区系显著减轻了炎症。此外,豆甾醇处理促进了肠道微生物区系衍生的短链脂肪酸(SCFA)的产生,特别是丁酸盐。接下来,在Treg或Th17极化的条件下培养从IBD患者中分离出来的人幼稚的CD4+T细胞;补充丁酸可以增加Treg的分化,降低Th17细胞的分化。从机制上讲,丁酸盐可激活过氧化物酶体增殖物激活受体γ,重新编程能量代谢,从而促进Treg的分化,抑制Th17的分化。我们的结果表明,丁酸介导的PPARγ激活恢复了Treg/Th17细胞的平衡,这可能是豆甾醇减轻IBD的一个可能机制。
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with gut microbiota disequilibrium and regulatory T (Treg)/T helper 17 (Th17) immune imbalance. Stigmasterol, a plant-derived sterol, has shown anti-inflammatory effects. Our study aimed to identify the effects of stigmasterol on experimental colitis and the related mechanisms. Stigmasterol treatment restored the Treg/Th17 balance and altered the gut microbiota in a dextran sodium sulfate (DSS)-induced colitis model. Transplantation of the faecal microbiota of stigmasterol-treated mice significantly alleviated inflammation. Additionally, stigmasterol treatment enhanced the production of gut microbiota-derived short-chain fatty acids (SCFAs), particularly butyrate. Next, human naïve CD4+ T cells sorted from IBD patients were cultured under Treg- or Th17-polarizing conditions; butyrate supplementation increased the differentiation of Tregs and decreased Th17 cell differentiation. Mechanistically, butyrate activated peroxisome proliferator-activated receptor gamma (PPARγ) and reprogrammed energy metabolism, thereby promoting Treg differentiation and inhibiting Th17 differentiation. Our results demonstrate that butyrate-mediated PPARγ activation restores the balance of Treg/Th17 cells, and this may be a possible mechanism, by which stigmasterol attenuates IBD.